Venaxis Inc news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

APPY 2.73 -0.07 (-2.50%)
price chart
Form SC 13D/A Venaxis, Inc. Filed by: DeFrancesco Catherine Johanna
2) respectively, relating to the common stock, no par value (the “Common Stock”), of Venaxis, Inc. a Colorado corporation (the “Issuer”).
Making Waves: Penny Stock Update on Venaxis, Inc. (NASDAQ:APPY)
Venaxis, Inc. (NASDAQ:APPY)'s share price changed -2.54% after a recent trade, sending the price to $2.65, drawing interest from investors.
Venaxis Inc. APPY (US: Nasdaq)
Venaxis Inc. APPY (U.S.: Nasdaq). search. View All companies. AT CLOSE 4:00 PM EDT 10/18/16. $2.72 USD; 0.22 8.80%.
Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ ...
CASTLE ROCK, Colo., Sept. 23, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced that on September 21, 2016, the Company approved the grant of stock options to six new employees, hired in connection with the Company's acquisition of ...
Venaxis Announces Acquisition of BiOptix
CASTLE ROCK, Colo., Sept. 13, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced today that it has acquired BiOptix Diagnostics, Inc., ("BiOptix") a Boulder, CO-based privately-held company. BiOptix has developed a proprietary Enhanced ...
Venaxis buys drug discovery technology firm BiOptix Diagnostics  Seeking Alpha
Stock Flexing Muscles Mid-session: Venaxis, Inc. (NASDAQ:APPY)
Shares of Venaxis, Inc. (NASDAQ:APPY) are scrambling higher in today's trading session. At the time of writing, the stock had reached $2.89.
Shorts On Watch: Will Venaxis Incorporated (NASDAQ:APPY) Run Out of Steam ...  Post News
New Broker Views On Venaxis, Inc. (APPY)  Fiscal Standard
Venaxis Inc (NASDAQ:APPY) Is Finally Poised For Growth
Venaxis Inc (NASDAQ:APPY) just announced its acquisition of biomedical device company BiOptix, and it looks as though markets are uncertain as to what the transaction means for the company going forward.
New Broker Ratings For Venaxis, Inc. (APPY)  FTSE News
Venaxis Issues Shareholder Update
20, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced today that following its acquisition of BiOptix Diagnostics, Inc., ("BiOptix") that was announced on September 13, 2016, Venaxis has issued the following letter to its shareholders. The ...
Big Venaxis shareholder, company CEO in mudslinging melee
Venaxis Announces Transaction with Strand Life Sciences
CASTLE ROCK, Colo., Jan. 26, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced today that it has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited (Strand LS) and its shareholders.
Venaxis to merge with Strand Life Sciences  Seeking Alpha
Venaxis (APPY) Enters Merger Agreement with Strand LS
Share Value Diminishing Over Past Month: Venaxis, Inc. (NASDAQ:APPY)
Venaxis, Inc. (NASDAQ:APPY) shares have slid down over the previous month, which may be worrying some investors. After a recent check, the stock has been down -42.72% for the month.